Tus kws kho mob
P1-18 New Drugs, Aimovig (erenumab), Fremanezumab and Galcanezumab Will Require PA
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 09, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 2851 - 2860 ntawm 4179
Tus kws kho mob
2018 May Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2018
Tus kws kho mob
P25-17 Addition of New Drugs to the Hepatitis C Second Generation Antivirals Prior Authorization (PA) with Quantity Limit (QL) Program
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P32-17 Minnesota Senior Health Options Model of Care Requirements
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 12, 2017
Tus kws kho mob
P72-17 New Availity Functionality Available to Create and Submit an Electronic Referral
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 17, 2017
Tus kws kho mob
P73-17 A New Drug, Hemlibra (emicizumab) Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2017
Tus kws kho mob
P14-17 Medical Drug Management
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 10, 2017
Tus kws kho mob
P23-17 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 16, 2017
Tus kws kho mob
P2-17 Updated: Change in Coverage for Detoxification Services for Minnesota Health Care Programs Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2017
Tus kws kho mob
P29-17 New Drug-Related Prior Authorization (PA) Criteria: Erythropoietins
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 05, 2017